Date:November 19, 2020 By:Admin
Oxford-India Covid Vaccine in Trails, Raises Big Hope: Produced Strong Immunity in Older Adults
Oxford-India Vaccine in Trails, Raises Big Hope: Produced Strong Immunity in Older Adults
While the second wave of Corona is creating tremors across the world, the latest news on Vaccine trials has brought some hope and confidence to the people across the globe.
Currently, the developed nations like the USA, UK, France, Germany, and few European nations are in the clutches of covid-19’s second wave, millions of positive cases are being reported and more deaths are also being reported from the past few weeks in these nations, the second wave looks more menacing than the initial outbreak. The United Kingdom imposed a lockdown again to control the harsh spread.
Epidemiologists and medical professionals opine that India yet not finished the first wave. The Indian government recently revealed that Indian is in a safe position with a 93% plus recovery rate though lakhs of positive cases are present.
Here comes a ray of hope among people, leaders worldwide
A covid vaccine that is under mid trials has shown good progress by producing strong immunity in old age people belonging to 60s and 70s.
It is a known fact that the Covid19 virus poses a big threat to old adults.
The latest research on the Corona vaccine by Oxford-AstraZeneca (India Pharmacy Company) is yielding fine results so far.
Around 560 adult volunteers have participated in vaccine trials and 99 percent of them got strong immunity
India Company AstraZeneca Vaccine Is Frontrunner
India’s one of the reputed bio-pharmaceutical firms AstraZeneca collaborated with the eminent university, Oxford, for the production of the best vaccine to terminate covid-19. The trails are going on with positive outcomes.
The latest experiment of AstraZeneca vaccine on old age persons has been very successful by producing 99 Percent immunity against covid.
The AstraZeneca vaccine is the front runner compared to Pfizer Inc-BioNTech and Moderna Inc., which have reported 90 percent effectiveness over the past week
However, Pfizer Inc-BioNTech and Moderna Inc vaccines are likely to be more expensive, they are using the latest technology called messenger RNA (mRNA).
AstraZeneca's vaccine is made from a weak section of a common cold virus that infects Chimpanzees.
AstraZeneca vaccine is likely to be available at fewer costs, after successful research, invention, and production.
It's good news for all Indians as well. Let's say all the best for the upcoming trails.